![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 Cohance Lifesciences (3)
02 Granules India Limited (2)
03 Ascent Innovative Medicines (2)
04 Aspire Lifesciences Pvt Ltd (1)
05 Kolmar Korea Co., Ltd. (2)
06 Laboratorio Eczane Pharma (2)
07 Orchid Chemicals & Pharmaceuticals Ltd (2)
08 Pelcoat Formulations (4)
09 World Medicine (2)
01 Dexlansoprazole (20)
01 CAPSULE (2)
02 Caplet (2)
03 Capsule (4)
04 DR CAPSULE (2)
05 DR Capsule (2)
06 Delayed Release Pellet (1)
07 Enteric Coated Pellets (4)
08 Pellets (1)
09 Tablet (2)
01 15%/W/W (1)
02 17%/W/W (1)
03 17%W/W (1)
04 20%/W/W (1)
05 22.5% (1)
06 30MG (7)
07 60MG (7)
08 8.5%/W/W (1)
01 Argentina (2)
02 India (14)
03 South Korea (2)
04 Turkey (2)